Eric Warren, Chief Commercial Officer: Esperion Therapeutics ESPR Sell · Filed 25/04/21

Trade details

Type: Insider sale
Amount: $105.84
Shares · price: 108 sh · $0.98 a share
Held after: 370,218 sh
Stock: Esperion Therapeutics ESPR
Person: Eric WarrenChief Commercial Officer
Trade date: 25/04/17
Filed: 25/04/21
Days to filing: 4 days

Sold under 0.1% of holdings

Share of holding sold: under 0.1%

Esperion Therapeutics trades, last 26 weeks

What else happened in Esperion Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/18~25/05/17

Eric Warren's recent trades

Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$209.1K
7,438 sh
$209.1K
Filed 09/21
Traded 09/21
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$193.2K
7,437 sh
$193.2K
Filed 08/21
Traded 08/21
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$199.9K
7,438 sh
$199.9K
Filed 07/21
Traded 07/21
Eric WarrenChief Commercial Officer
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$2.7M
104,124 sh
$2.7M
Filed 06/30
Traded 06/26
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2.7M
104,124 sh
$2.7M
Filed 06/29
Traded 06/26

Eric Warren, Chief Officer — sold $106 of Esperion Therapeutics ESPR · under 0.1% of holdings | Whalegun